PD L2 (PDCD1LG2) Mouse Monoclonal Antibody [Clone ID: OTI6H10]

CAT#: TA808996S

PDCD1LG2 mouse monoclonal antibody, clone OTI6H10 (formerly 6H10)

Product Images

HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY PDCD1LG2 (RC224141, Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-PDCD1LG2 (1:500). Positive lysates LY410802 (100ug) and LC410802 (20ug) can be purchased separately from OriGene.

• 

  Flow cytometric analysis of living 293T cells transfected with PDL2 overexpression plasmid (RC224141, Red)/empty vector (PS100001, Blue) using anti-PDL2 antibody (TA808996). Cells incubated with a non-specific antibody (Green) were used as isotype control (1:100).

Specifications

Product Data

• Clone Name: OTI6H10
• Applications: FC, WB
• Recommended Dilution: WB 1:500
• Reactivities: Human
• Host: Mouse
• Isotype: IgG1
• Clonality: Monoclonal
• Immunogen: Full length human recombinant protein of human PDCD1LG2 (NP_079515) produced in HEK293T cell.
• Formulation: PBS (PH 7.3) containing 1% BSA, 50% glycerol and 0.02% sodium azide.
• Concentration: 1 mg/ml
• Purification: Purified from mouse ascites fluids or tissue culture supernatant by affinity chromatography (protein A/G)
• Conjugation: Unconjugated
• Storage: Store at -20°C as received.
• Stability: Stable for 12 months from date of receipt.
• Predicted Protein Size: 30.8 kDa
• Gene Name: programmed cell death 1 ligand 2
• Database Link:
  NP_079515
  Entrez Gene 80380 Human
  UniProt ID Q9BQ51
• Background: Involved in the costimulatory signal, essential for T-cell proliferation and IFNG production in a PDCD1-independent manner. Interaction with PDCD1 inhibits T-cell proliferation by blocking cell cycle progression and cytokine production. [UniProtKB/Swiss-Prot Function]
• Synonyms: B7DC; bA574F11.2; Btdc; CD273; PD-L2; PDCD1L2; PDL2

Reference Data

• Protein Families: Transmembrane
• Protein Pathways: Cell adhesion molecules (CAMs)